Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus

MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression

Luca Scapoli, Annalisa Palmieri, Lorenzo Lo Muzio et al. · International Journal of Immunopathology and Pharmacology · 2010 · 236 citations

Tumor Progression, Pathology, Thirteen Mirna +16

KRAS and BRAF mutations in ovarian tumors: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants

Doris Mayr, Astrid Hirschmann, U. Löhrs et al. · Gynecologic Oncology · 2006 · 221 citations

Tumoral Pathology, Tumor Heterogeneity, Medicine +9

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

Recep Bayraktar, Martin Pichler, Pınar Kanlikilicer et al. · Oncotarget · 2016 · 152 citations · Full text

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Mitchell Stark, Kerenaftali Klein, Benjamin Weide et al. · EBioMedicine · 2015 · 100 citations · Full text

Melanoma Tissues, Engineering, Immunology +23

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer

Masayuki Hiraki, Junichi Nishimura, Hidekazu Takahashi et al. · Molecular Therapy — Nucleic Acids · 2015 · 95 citations · Full text